skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:054775/0546   Pages: 9
Recorded: 11/19/2020
Attorney Dkt #:TRIZELL
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 36
1
Patent #:
7071183
Issue Dt:
07/04/2006
Application #:
10206659
Filing Dt:
07/26/2002
Publication #:
US20020187939
Pub Dt:
12/12/2002
Title:
USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
2
Patent #:
7071183
Issue Dt:
07/04/2006
Application #:
10206659
Filing Dt:
07/26/2002
Publication #:
US20020187939
Pub Dt:
12/12/2002
Title:
USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
3
Patent #:
7998953
Issue Dt:
08/16/2011
Application #:
11119181
Filing Dt:
04/29/2005
Publication #:
US20050192327
Pub Dt:
09/01/2005
Title:
USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
4
Patent #:
7998953
Issue Dt:
08/16/2011
Application #:
11119181
Filing Dt:
04/29/2005
Publication #:
US20050192327
Pub Dt:
09/01/2005
Title:
USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
5
Patent #:
8003679
Issue Dt:
08/23/2011
Application #:
11441648
Filing Dt:
05/25/2006
Publication #:
US20060217429
Pub Dt:
09/28/2006
Title:
USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
6
Patent #:
8003679
Issue Dt:
08/23/2011
Application #:
11441648
Filing Dt:
05/25/2006
Publication #:
US20060217429
Pub Dt:
09/28/2006
Title:
USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
7
Patent #:
NONE
Issue Dt:
Application #:
12522646
Filing Dt:
07/09/2009
Publication #:
US20100003746
Pub Dt:
01/07/2010
Title:
Production of Lentiviral Vectors
8
Patent #:
8188039
Issue Dt:
05/29/2012
Application #:
12599294
Filing Dt:
08/20/2010
Publication #:
US20110144013
Pub Dt:
06/16/2011
Title:
VEGF-D MUTANTS AND THEIR USE
9
Patent #:
8188039
Issue Dt:
05/29/2012
Application #:
12599294
Filing Dt:
08/20/2010
Publication #:
US20110144013
Pub Dt:
06/16/2011
Title:
VEGF-D MUTANTS AND THEIR USE
10
Patent #:
8604070
Issue Dt:
12/10/2013
Application #:
13360895
Filing Dt:
01/30/2012
Publication #:
US20120178784
Pub Dt:
07/12/2012
Title:
USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
11
Patent #:
8604070
Issue Dt:
12/10/2013
Application #:
13360895
Filing Dt:
01/30/2012
Publication #:
US20120178784
Pub Dt:
07/12/2012
Title:
USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
12
Patent #:
NONE
Issue Dt:
Application #:
13969763
Filing Dt:
08/19/2013
Publication #:
US20140057851
Pub Dt:
02/27/2014
Title:
Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
13
Patent #:
NONE
Issue Dt:
Application #:
15306830
Filing Dt:
10/26/2016
Publication #:
US20170051309
Pub Dt:
02/23/2017
PCT #:
US2015046927
Title:
Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time
14
Patent #:
10335461
Issue Dt:
07/02/2019
Application #:
15430456
Filing Dt:
02/11/2017
Publication #:
US20170232071
Pub Dt:
08/17/2017
Title:
Interferon Therapy
15
Patent #:
10335461
Issue Dt:
07/02/2019
Application #:
15430456
Filing Dt:
02/11/2017
Publication #:
US20170232071
Pub Dt:
08/17/2017
Title:
Interferon Therapy
16
Patent #:
11261416
Issue Dt:
03/01/2022
Application #:
15579208
Filing Dt:
12/03/2017
Publication #:
US20190031998
Pub Dt:
01/31/2019
Title:
Fixed-Bed Bioreactor With Constant-Flow Pump / Tubing System
17
Patent #:
NONE
Issue Dt:
Application #:
15672330
Filing Dt:
08/09/2017
Publication #:
US20190060313
Pub Dt:
02/28/2019
Title:
Immuno-Gene Combination Therapy
18
Patent #:
11104915
Issue Dt:
08/31/2021
Application #:
15754598
Filing Dt:
02/23/2018
Publication #:
US20190338307
Pub Dt:
11/07/2019
Title:
Viral Vector Assay and Vector
19
Patent #:
11932843
Issue Dt:
03/19/2024
Application #:
15763123
Filing Dt:
03/26/2018
Publication #:
US20200172847
Pub Dt:
06/04/2020
Title:
Adherent Cell Culture Substrate Sampling Device
20
Patent #:
11781102
Issue Dt:
10/10/2023
Application #:
15777228
Filing Dt:
05/18/2018
Publication #:
US20200165557
Pub Dt:
05/28/2020
Title:
Large-Scale PEI-Mediated Plasmid Transfection
21
Patent #:
11311487
Issue Dt:
04/26/2022
Application #:
15781707
Filing Dt:
06/06/2018
Publication #:
US20200129436
Pub Dt:
04/30/2020
PCT #:
US2017025727
Title:
Viral Vector Stabilization
22
Patent #:
NONE
Issue Dt:
Application #:
16268548
Filing Dt:
02/06/2019
Publication #:
US20190167690
Pub Dt:
06/06/2019
Title:
Immuno-Gene Combination Therapy
23
Patent #:
NONE
Issue Dt:
Application #:
16280174
Filing Dt:
02/20/2019
Publication #:
US20190255153
Pub Dt:
08/22/2019
Title:
Interferon Therapy
24
Patent #:
NONE
Issue Dt:
Application #:
16299221
Filing Dt:
03/12/2019
Publication #:
US20190276846
Pub Dt:
09/12/2019
Title:
Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time
25
Patent #:
11242504
Issue Dt:
02/08/2022
Application #:
16357532
Filing Dt:
03/19/2019
Publication #:
US20190218495
Pub Dt:
07/18/2019
Title:
Aseptic Bioreactor Sampling System
26
Patent #:
NONE
Issue Dt:
Application #:
16364284
Filing Dt:
03/26/2019
Publication #:
US20190275106
Pub Dt:
09/12/2019
Title:
Anti-Angiogenic Gene Therapy Kit
27
Patent #:
NONE
Issue Dt:
Application #:
16426124
Filing Dt:
05/30/2019
Publication #:
US20190292609
Pub Dt:
09/26/2019
Title:
Gene Therapy Vector Contamination Assay
28
Patent #:
NONE
Issue Dt:
Application #:
16456066
Filing Dt:
06/28/2019
Publication #:
US20190314378
Pub Dt:
10/17/2019
Title:
Gene Therapy For Mesothelioma
29
Patent #:
NONE
Issue Dt:
Application #:
16458275
Filing Dt:
07/01/2019
Publication #:
US20200360499
Pub Dt:
11/19/2020
Title:
CDKN2a Companion Diagnostic for Bladder Cancer Interferon Therapy
30
Patent #:
NONE
Issue Dt:
Application #:
16458275
Filing Dt:
07/01/2019
Publication #:
US20200360499
Pub Dt:
11/19/2020
PCT #:
US2018064829
Title:
CDKN2a Companion Diagnostic for Bladder Cancer Interferon Therapy
31
Patent #:
NONE
Issue Dt:
Application #:
16601698
Filing Dt:
10/15/2019
Publication #:
US20210106674
Pub Dt:
04/15/2021
Title:
Gene Therapy For Mesothelioma
32
Patent #:
10829785
Issue Dt:
11/10/2020
Application #:
16681964
Filing Dt:
11/13/2019
Publication #:
US20200071725
Pub Dt:
03/05/2020
Title:
Nucleic Acid Application Primers
33
Patent #:
10829785
Issue Dt:
11/10/2020
Application #:
16681964
Filing Dt:
11/13/2019
Publication #:
US20200071725
Pub Dt:
03/05/2020
Title:
Nucleic Acid Application Primers
34
Patent #:
NONE
Issue Dt:
Application #:
16702782
Filing Dt:
12/04/2019
Publication #:
US20200222477
Pub Dt:
07/16/2020
Title:
Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive Cancer
35
Patent #:
11547668
Issue Dt:
01/10/2023
Application #:
16931600
Filing Dt:
07/17/2020
Publication #:
US20200352861
Pub Dt:
11/12/2020
Title:
Viral Vector Stabilization
36
Patent #:
11446249
Issue Dt:
09/20/2022
Application #:
16931615
Filing Dt:
07/17/2020
Publication #:
US20200352862
Pub Dt:
11/12/2020
Title:
Viral Vector Stabilization
Assignor
1
TRIZELL LTD.
Exec Dt:
01/06/2009
Assignee
1
PHARMACEUTICAL PATENT ATTORNEYS, LLC
55 MADISON AVENUE,
4TH FLOOR
MORRISTOWN, NEW JERSEY 07960-7397
Correspondence name and address
MARK POHL
55 MADISON AVENUE,
4TH FLOOR
MORRISTOWN, NJ 07960-7397

Search Results as of: 09/21/2024 03:18 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT